Cynosure Inc.
Tattoo-removal: Cynosure wins FDA nod for PicoSure laser workstation
Aesthetics devices maker Cynosure (NSDQ:CYNO) received FDA clearance for its PicoSure laser workstation, a device designed for the removal of tattoos and benign pigmented lesions.
The study based on 22 people demonstrated greater than 80% overall tattoo clearance, and 94% removal for blue and green ink over 2 weeks, according to a press release.
Diabetes: Intarcia pulls down $210M for drug-device combo| Wall Street Beat
Intarcia Therapeutics said it’s reeled in financing worth a total of $210 million to further its drug-device combination treatment for Type II diabetes.
The Hayward, Calif.-based company, which is moving its headquarters to Boston, said the cash will also help facilitate the move.
Nihon Kohden grabs Defibtech | Wall Street Beat
Cynosure blows away expectations for 4th consecutive quarter
By the numbers: The aesthetic medical device market picks up during the 2nd quarter
The market for aesthetic medical devices gained some ground during the 2nd quarter, a MassDevice.com analysis shows, although healthy sales growth didn’t necessarily translate into healthy bottom lines for all comers.
Sunshine Heart soars on C-Pulse CE Mark | Wall Street Beat
Sunshine Heart (ASX:SHC) is shining on Wall Street today after announcing European regulatory approval for its C-Pulse heart assist system, with SHC shares closing up nearly 14% on the news.
Home wrinkle treatment wins FDA clearance
MassDevice.com +3 | The top 3 med-tech stories for May 1, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Lawyers probe Cynosure execs’ pay as Q1 sales, profits soar
Will Advanced BioHealing pay off for Shire with a buyout deal? | Wall Street Beat
Buyout chatter pushed shares of Shire plc (FTSE:SHP) up nearly 2% in London yesterday and added 1.4% on Wall Street.